Composition to improve tear stains on companion animals and preparation thereof

A feed composition with Bacillus polyfermenticus and additional additives addresses tear stains by balancing intestinal microbiome and promoting porphyrin consumption, effectively reducing tear stains and improving pet appearance.

KR103043840B1Active Publication Date: 2026-11-06여장욱
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
KR1020240069037
Authority / Receiving Office
KR · KR
Patent Type
Patents
Current Assignee / Owner
Priority Date
2023-06-12
Filing Date
2024-05-28
Publication Date
2026-11-06
Estimated Expiration
2044-05-28

AI Technical Summary

Technical Problem

Tear stains in pets, particularly due to porphyrin leakage and bacterial proliferation, cause emotional distress to owners and can lead to secondary skin and eye conditions.

Method used

A supplementary feed composition containing Bacillus polyfermenticus as an active ingredient, combined with antioxidants, food for beneficial intestinal bacteria, vegetable fat powder, and colostrum powder, to inhibit porphyrin synthesis and promote its consumption, thereby addressing the underlying cause of tear stains.

Benefits of technology

The feed composition effectively reduces tear stains by regulating intestinal microbiome balance, enhancing immune function, and promoting eye health, as demonstrated by significant improvements in pet fur coloration.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 112024057536983-PAT00013_ABST
    Figure 112024057536983-PAT00013_ABST
Patent Text Reader

Abstract

A composition for improving, preventing, or treating tear stains in pets contains Bacillus polyfermenticus as an active ingredient.
Need to check novelty before this filing date? Find Prior Art

Description

Technology Field

[0001] The present invention relates to a supplementary feed composition for pets, and more specifically, to a supplementary feed composition capable of improving tear stains in pets. Background Technology

[0002] Pets (dogs, cats, etc.) live with humans and share joys and sorrows as members of the family. Even though most pets are not ill or have specific eye conditions, issues such as tear stains (or 'tear spots') often cause emotional distress to their owners, even if the pets themselves may not be aware of it. In many cases, this cannot be improved without the owner's care.

[0003] Tear stains are known to occur when porphyrin components present in mammalian blood leak out with tears due to poor blood circulation around the eyes, react with sunlight to turn red, and cause the fur around the eyes to become discolored. Another known cause is that brown tear stains result from the proliferation of yeast and bacteria around the eyes due to nutrients present in tears.

[0004] By maintaining the health of your pet through vaccinations or the active care and treatment of veterinarians for infections or internal and surgical diseases, they will be able to live a long and happy life with their owner.

[0005] However, while tear stains themselves are not a specific ophthalmic disease for pets, they are unsightly and often cause emotional distress to the owners living with them. If the tear stains worsen, they may be accompanied by skin conditions such as itching around the eyes or hair loss, and can lead to secondary diseases, such as serious eye diseases caused by physical irritation from the dog scratching due to itching. Prior art literature

[65535] Patent Document 1: Korean Patent Application Publication No. 10-2007-0054972 The problem to be solved

[0006] The object of the present invention is to provide a composition, an auxiliary feed additive, and a method for manufacturing the same that can improve, prevent, or treat tear stains in pets. means of solving the problem

[0007] A composition for improving, preventing, or treating tear stains according to one embodiment for achieving the objective of the present invention comprises Bacillus polyfermenticus as an active ingredient.

[0008] An auxiliary feed additive for improving, preventing, or treating tear stains according to one embodiment for achieving the objective of the present invention comprises Bacillus polyfermenticus as an active ingredient.

[0009] The above-mentioned supplementary feed additive further includes at least one supplementary additive among antioxidants, color supplements, food for beneficial intestinal bacteria, vegetable fat powder, and colostrum powder.

[0010] A method for manufacturing an auxiliary feed additive for improving, preventing, or treating tear stains according to one embodiment for achieving the objective of the present invention comprises a first process of weighing and mixing raw materials, a second process of filling the mixture prepared in the first process in a capsule filling machine, and a third process of blister packaging the capsules prepared in the second process. Effects of the invention

[0011] According to embodiments of the present invention, tear stains on pets can be improved. Brief explanation of the drawing

[0012] FIGS. 1 and 2 are photographs taken of the area around the eyes of a pet before and after consuming an auxiliary feed additive according to embodiments of the present invention, and it can be seen that tear stains are improved after consuming an auxiliary feed additive according to one embodiment of the present invention. Specific details for implementing the invention

[0013] For the purposes of this specification and claims, unless otherwise stated, all numbers representing quantities, percentages or ratios and other figures used in this specification and claims should be understood as being modified by the term “approximately” in all cases. The use of the term “approximately” applies to all numeric values, whether or not explicitly indicated. This term generally refers to a range of numbers that a person skilled in the art might consider to be a reasonable amount of deviation from the stated figures (i.e., having equivalent function or result). For example, this term may be interpreted to include deviations of ± 10%, alternatively ± 5%, alternatively ± 1%, alternatively ± 0.5%, and alternatively ± 0.1% for a given range of numbers that do not alter the final function, effect, or result of that range of numbers. Accordingly, unless otherwise indicated, the numeric parameters presented in this specification and claims are approximations that may vary depending on the desired characteristics obtained by the present invention.

[0014] For the purposes of this specification and claims, the terms ‘and / or’ and ‘and / or’ mean any single or any combination of the listed components, compositions, etc.

[0016] Tear stains and general treatment methods

[0017] Tear stains are common in light-colored breeds and frequently occur in breeds with anatomical features such as short noses, large eyes, and flat faces, including Shih Tzus, Malteses, Bichons, Pomeranians, Poodles, Bulldogs, Boxers, Pugs, Boston Terriers, Cocker Spaniels, Schnauzers, Dachshunds, Samoyeds, Labrador Retrievers, and Golden Retrievers.

[0018] Tear stains refer to cases where the fur around a pet's eyes (e.g., the fur under the eyes) turns brown. If the animal is infected with a fungus such as Malassezia, a sour odor may also be present. Many pet owners worry about these tear stains, and if the condition is not due to a specific ophthalmic disease (conjunctivitis, keratitis, or uveitis), it is referred to as epiphora.

[0019] The causes of epiphora are as follows: 1) eyelashes poking or irritating the inner corner of the eye; 2) excessive tearing due to eye pain caused by corneal ulcers or other causes; 3) blockage or malformation of the tear drainage system (tear duct); 4) increased tearing due to other factors such as dietary allergies or stress.

[0021] The following can be considered as conventional treatments based on the causes of the tear stains mentioned above:

[0022] If the lacrimal duct is blocked, it must be widened at an animal hospital through a procedure to ensure smooth tear drainage. However, in such cases, it is common for the duct to narrow again, leading to a recurrence of epiphora.

[0023] You must provide eyelash care, control the diet (avoid foods high in iron, such as beef), and create an environment that minimizes stress. Once tear stains form, gently wipe them away with a cotton pad soaked in saline solution or artificial tears, taking care to avoid contact with the eyes. You can also clean the area around the eyes using a contact lens cleaning solution containing boric acid.

[0024] Drinking water should be purified distilled water rather than tap or well water. This is because tap and well water may contain iron and other minerals that can worsen stains. Switching to a beef-free diet can help reduce porphyrin.

[0026] Fundamental treatment method for tear stains according to the present invention

[0027] Tears contain porphyrin, a substance that combines with iron and turns reddish-brown when exposed to light. Therefore, when a pet sheds tears, the area where the tears were becomes discolored, leaving a tear stain.

[0028] Porphyrin is a general term for substances containing cofactors essential for energy transfer and biosynthetic processes, such as cytochrome, heme, chlorophyll, and coenzyme B12, and is an iron-containing molecule produced when the body breaks down iron. Porphyrin is excreted through the gastrointestinal tract, urine, saliva, and tears.

[0029] Accordingly, the applicant has proposed the present invention by noting that porphyrin is the fundamental cause of tear stains. The technical concept of the present invention is to prevent, improve, or treat tear stains by suppressing the production of porphyrin, which is the fundamental cause of tear stains, and promoting its consumption.

[0031] Mechanism of Porphyrin Synthesis and Consumption

[0032] To formulate strategies for inhibiting porphyrin production and promoting its consumption, it is necessary to understand the mechanisms of porphyrin synthesis and consumption. The schematic diagram below summarizes the mechanisms of porphyrin synthesis and consumption according to a normal gut microbiome:

[0033]

[0034] First, we examine the mechanism of porphyrin synthesis. Intestinal Escherichia coli (E. coli) synthesizes aminolevric acid using succinyl, and two molecules condense to synthesize porphobilinogen (the initial precursor containing the porphyrin molecular structure). Porphobilinogen is converted into protoporphyrin through four steps by five types of catalysts. Protoporphyrin reacts with iron ions using enzymes to synthesize heme. When a sufficient amount of heme is synthesized, the synthesis of porphobilinogen is inhibited, and the remaining heme is excreted as waste.

[0035] Meanwhile, intestinal bacterioides inhibit the synthesis of porphyrin by consuming porphobilinogen.

[0036] In other words, from the perspective of the gastrointestinal microbiome, harmful bacteria, including E. coli, produce large amounts of porphyrin, while beneficial gut flora such as Bacteroides require porphyrin for normal growth. Probiotics that consume Bacteroides and other porphyrins are found in the intestines of dogs. These good bacteria also play a role in suppressing yeast populations. When the balance between good and bad bacteria is disrupted and bad bacteria become dominant in the gut, more porphyrin is produced. Since less of this porphyrin is consumed by the dog's gut microbiota, the concentration of porphyrin in tears increases, becoming a significant cause of tear stains.

[0037] If harmful bacteria such as E. coli become the dominant bacteria in the intestines, the likelihood of tear stains occurring will increase, as understood from the diagram below:

[0038]

[0040] Therefore, the fundamental prevention, improvement, and / or treatment of tear stains involves inhibiting the synthesis of porphyrin, which is the underlying cause, and promoting its consumption, and clues can be found from the schematic diagrams above. That is, the present invention thus provides a method for preventing, improving, and / or treating tear stains by inhibiting the synthesis of porphyrin and promoting its consumption through a method that helps the intestinal microbiome inhibit E. coli and promote the proliferation of Bacteroides, and / or by providing such an intestinal environment.

[0042] Meanwhile, Bacillus polyfermenticus (Bacillus polyfermenticus) BP2 is a type of spore-forming bacterium that produces macrolactin A as a metabolite, which exhibits excellent antimicrobial activity against microorganisms and fungi, including E. coli.

[0043] Accordingly, the present invention prevents, improves, and / or treats tear stains by using Bacillus polyfermenticus to inhibit intestinal Escherichia coli and proliferate Bacteroides. Accordingly, embodiments of the present invention provide a composition for preventing, improving, and / or treating tear stains, an auxiliary feed additive, and a method for manufacturing the same, wherein Bacillus polyfermenticus is an active ingredient.

[0044] As in the present invention, when Bacillus polyfermenticus is used, tear stains will be reduced, as understood from the schematic diagram below:

[0045]

[0047] The effects of applying Bacillus polyfermenticus compared to non-application are summarized in the table below:

[0048]

[0050] In addition, the effect can be enhanced by applying a food source for beneficial intestinal bacteria—specifically Bacteroides—in combination with Bacillus polyfermenticus to aid in their proliferation. This food source for beneficial intestinal bacteria includes fructooligosaccharides and indigestible maltodextrin.

[0052] The present invention will be explained in more detail below through examples. However, the following examples and experimental examples are presented as illustrative examples of the present invention and are not intended to limit the present invention. Various modifications and applications of the present invention are possible within the scope of the claims set forth below and the equivalent scope interpreted therefrom.

[0054] Various aspects of the present invention relate to compositions and feed additives capable of preventing, improving, and / or treating tear stains in companion animals.

[0055] One aspect of the present invention provides a composition for preventing, improving, and / or treating tear stains in pets, comprising Bacillus polyfermenticus as an active ingredient. That is, one aspect of the present invention provides a new use for Bacillus polyfermenticus, namely, a new use for preventing, improving, and / or treating tear stains in pets.

[0057] Another aspect of the present invention provides a feed additive for preventing, improving, and / or treating tear stains in companion animals, comprising Bacillus polyfermenticus as an active ingredient. The feed additive according to the present aspect comprises Bacillus polyfermenticus as an active ingredient.

[0058] The above-mentioned supplementary feed additive comprises at least one supplementary additive among food for beneficial intestinal bacteria, antioxidants, pigment supplements, vegetable fat powder, and colostrum powder.

[0059] The above-mentioned food for beneficial intestinal bacteria includes at least one of fructooligosaccharide and resistant maltodextrin. Resistant maltodextrin is a type of MAC (Microbiota-Accessible Carbohydrate) that cannot be digested by the human body but can be digested by microorganisms, and serves as food for various beneficial bacteria such as Bifidobacteria and Bacteroides, making the intestinal microbiome a dietary fiber.

[0060] The above antioxidant comprises at least one of: beta-carotene, which is converted into vitamin A and maintains vision and functions of the cornea and conjunctiva; theracumin; astaxanthin; bilberry extract, which contains anthocyanin and is beneficial for eye health; grape seed extract, which contains procyanidin and is beneficial for eye health; and milk seed extract, which contains silymarin.

[0061] Beta-carotene is a type of carotenoid that serves as a precursor to Vitamin A in the body and is a powerful antioxidant with excellent eye protection and free radical scavenging properties; however, since it cannot be synthesized in the body, it must be obtained through food.

[0062] Anthocyanins (precursors of anthocyanidins) and proanthocyanidins are flavonoid compounds primarily found in fruits. They are widely known to aid in eye health and vision improvement, and are particularly powerful antioxidants with excellent ability to eliminate free radicals.

[0063] Theracumin is a water-soluble curcumin extracted from turmeric with enhanced absorption. By minimizing the particles of curcumin that are poorly absorbed, the absorption rate in the body is 42 times higher (curcumin particles 10–15 μm) compared to Theracumin (0.3–1.2 μm). Theracumin / curcumin possesses powerful antioxidant properties and stimulates the production of antioxidant enzymes in the body to eliminate oxidative stress (reactive oxygen species), which damages proteins and genes (DNA) and causes chronic inflammation if accumulated over time.

[0064] Astaxanthin is a red pigment belonging to a group of chemicals called carotenoids; it occurs in certain algae and causes the pink-red color in salmon. Astaxanthin can protect cells from damage.

[0065] Silymarin provides various benefits for liver health, such as protecting liver cells from oxidative stress, inhibiting the penetration of toxic substances into liver cells, increasing the activity of detoxification enzymes within liver cells, and suppressing the production and activation of inflammatory substances.

[0066] The above pigment supplement contains at least one of lutein and zeaxanthin, which are macular pigments that cannot be synthesized and therefore require intake. Lutein (zeaxanthin 1%) is a xanthophyll and is one of the 600 naturally occurring carotenoids known to date. It is synthesized only in plants and other xanthophylls and is found in large quantities in leafy vegetables such as spinach, kale, and yellow carrots. According to the description of raw materials for health functional foods by the Ministry of Food and Drug Safety, it may help maintain eye health by maintaining macular pigment density, which may decrease due to aging.

[0067] The above vegetable fat powder is a powder with canola oil as the main component, which maintains the homogeneity of the mixture and improves palatability.

[0068] The above colostrum powder is an ingredient for boosting immunity. Colostrum powder is a high-protein product containing 22% protein, is rich in immunoglobulin (|gG, IgA), lactoferrin, and growth factors (IGF, TGF), and contains much more nutrients such as vitamins A, D, E, and protein than regular milk.

[0070] Another aspect of the present invention provides a method for preparing a feed additive for preventing, improving, and / or treating tear stains in companion animals, comprising Bacillus polyfermenticus as an active ingredient.

[0071] An exemplary method for manufacturing the above feed additive is as follows:

[0072] Process 1: Weighing and mixing raw materials

[0073] Each raw material is accurately weighed in a predetermined weight ratio and mixed using a mixer.

[0074] Second process; manufacture of capsules

[0075] The mixture prepared in the first process above is filled in a capsule filling machine in a predetermined amount per capsule, for example, so that the weight becomes 500 mg.

[0076] Process 3: Aluminum blister packaging

[0077] The capsules manufactured by mixing in the second process above are packaged so that, for example, 10 capsules are filled into a blister pack. Through this process, the capsules are protected from light and moisture.

[0079] Example 1 Feeding additive for the prevention, improvement, and / or treatment of tear stains in pets

[0080] manufacturing process

[0081] Process 1: Weighing and mixing raw materials

[0082] Each raw material (the active ingredient Bacillus polyfermenticus and various auxiliary additives) is accurately weighed in equal weight ratios (weight%) as indicated in Table 1 and mixed using a mixer.

[0083]

[0084]

[0085] Second process; manufacture of capsules

[0086] The mixture prepared in the first process above is filled in a capsule filling machine so that the weight per capsule is 500 mg.

[0087] Process 3: Aluminum blister packaging

[0088] The capsules manufactured by mixing in the second process above are packaged so that 10 capsules are filled into each blister pack. Through this process, the capsules are protected from light and moisture.

[0089] Effectiveness test

[0090] The capsule-type feed additive of Example 1 was administered to a dog (Bichon breed) at a dose of two capsules per day for three weeks to check for improvement in tear stains.

[0091] As can be seen in Fig. 1, the capsule-type supplementary feed additive according to the present embodiment significantly improved tear stains in dogs.

[0093] The feed supplement of this embodiment contains Bacillus polyfermenticus, which has the functionality of regulating bowel movements, as a main ingredient. In particular, in the case of pets whose intestinal microbiome is in a state of dysbiosis, the concentration of porphyrin in tears may be reduced due to Bacillus polyfermenticus. Meanwhile, vegetable oil was used to enhance palatability, and colostrum powder was used to enhance immunity. Additionally, Theracumin, which has a powerful antioxidant effect, and lutein and astaxanthin, which are good for eye health, were used.

[0095] Example 2

[0096] ingredient

[0097] The components and formulations of the feed additive according to the present embodiment are as shown in Table 2 below:

[0098] Table 2

[0099]

[0101] manufacturing process

[0102] The feed additive according to the present embodiment is manufactured through the processes of weighing and mixing raw materials, manufacturing capsules, and aluminum blister packaging, similar to Example 1.

[0103] Effectiveness test

[0104] Test pets and feeding methods

[0105] The capsule-type supplementary feed additive according to the present embodiment was fed to pets (dogs and cats) aged 3 months or older for 3 weeks, and at this time, depending on the weight of the pet, 2 capsules were fed up to 10 kg, 3 capsules up to 20 kg, and 4 capsules up to 30 kg.

[0106] The breeds and ages of the dogs and cats participating in the test are as shown in Table 3 below:

[0107] Table 3

[0108]

[0109] As can be seen in Figure 2, the capsule-type supplementary feed additive according to the present embodiment significantly improved tear stains in dogs.

[0111] Tear stain improvement effect

[0112] The results of a survey conducted among pet owners regarding improvements in eye discharge, tears, and coloration after feeding the supplementary feed additive of the present embodiment to pets in the manner described above are shown in Table 4 below:

[0113] Table 4

[0114]

[0116] The feed additive of this example showed improvement effects of 86%, 80%, and 73% for each survey item.

[0118] Example 3

[0119] The components and formulations of the feed additive according to the present embodiment are as shown in Table 5 below:

[0120] Table 5

[0121]

[0122] The feed additive according to the present embodiment is manufactured through the processes of weighing and mixing raw materials, manufacturing capsules, and aluminum blister packaging, similar to Example 1.

[0124] Example 4

[0125] The components and formulation of the feed additive according to the present embodiment are as shown in Table 6 below:

[0126] Table 6

[0127]

[0128] The feed additive according to the present embodiment is manufactured through the processes of weighing and mixing raw materials, manufacturing capsules, and aluminum blister packaging, similar to Example 1.

[0130] Example 5

[0131] The components and formulation of the feed additive according to the present embodiment are as shown in Table 7 below:

[0132] Table 7

[0133]

[0134] The feed additive according to the present embodiment is manufactured through the processes of weighing and mixing raw materials, manufacturing capsules, and aluminum blister packaging, similar to Example 1.

[0136] Example 6

[0137] The components and formulations of the feed additive according to the present embodiment are as shown in Table 8 below:

[0138] Table 8

[0139]

[0140] The feed additive according to the present embodiment is manufactured through the processes of weighing and mixing raw materials, manufacturing capsules, and aluminum blister packaging, similar to Example 1.

Claims

Claim 1 A composition for improving, preventing, and / or treating tear stains in dogs and cats, comprising Bacillus polyfermenticus BP2 as an active ingredient. Claim 2 A feed additive for dogs and cats for improving tear stains, wherein the feed additive comprises Bacillus polyfermenticus BP2 as an active ingredient. Claim 3 In paragraph 2, the supplementary feed additive further comprises at least one supplementary additive selected from a food for beneficial intestinal bacteria, an antioxidant, a pigment supplement, a vegetable fat powder, and colostrum powder, wherein the food for beneficial intestinal bacteria comprises at least one selected from fructooligosaccharide and indigestible maltodextrin; the antioxidant comprises at least one selected from beta-carotene; theracumin; astaxanthin; bilberry extract; grape seed extract; and milk seed extract; the pigment supplement comprises at least one selected from lutein and zeaxanthin; and the vegetable fat powder comprises canola oil powder; a supplementary feed additive for dogs and cats. Claim 4 delete Claim 5 In paragraph 3, the above feed additive comprises 10 to 80 weight% of Bacillus polyfermenticus BP2, 1 to 10 weight% of colostrum powder, 0.1 to 2 weight% of theracumin, 1 to 10 weight% of lutein, 0.5 to 5 weight% of astaxanthin, and 5 to 30 weight% of vegetable fat powder, a feed additive for dogs and cats. Claim 6 In paragraph 3, the supplementary feed additive comprises: Bacillus polyfermenticus BP2; indigestible maltodextrin as food for beneficial intestinal bacteria; and at least one of bilberry extract and grape seed extract as an antioxidant, a supplementary feed additive for dogs and cats. Claim 7 In paragraph 3, the above feed additive is a feed additive for dogs and cats that includes the above intestinal beneficial bacteria food as the above feed additive. Claim 8 A supplementary feed additive for dogs and cats according to claim 6 or 7, wherein the intestinal beneficial bacteria food comprises at least one of fructooligosaccharide and indigestible maltodextrin. Claim 9 In claim 8, the above feed additive is a feed additive for dogs and cats, further comprising the above antioxidant and color supplement as the above feed additive. Claim 10 In claim 9, the antioxidant comprises at least one of beta-carotene; theracumin; astaxanthin; bilberry extract; grape seed extract; and milk seed extract, and the pigment supplement comprises at least one of lutein and zeaxanthin; a supplementary feed additive for dogs and cats. Claim 11 In paragraph 2, the supplementary feed additive further comprises a food for beneficial intestinal bacteria, wherein the food for beneficial intestinal bacteria comprises at least one of fructooligosaccharide and indigestible maltodextrin, a supplementary feed additive for dogs and cats. Claim 12 delete Claim 13 A method for manufacturing an additive for supplementary feed for dogs and cats according to claim 3, comprising the steps of: weighing each raw material in a predetermined weight ratio and mixing them using a mixer to form a raw material mixture; and filling the raw material mixture in a capsule filling machine to produce a capsule in a predetermined amount per capsule. Claim 14 A method for manufacturing a supplementary feed additive for dogs and cats, comprising, in addition to the step of blister packaging the capsules in claim 13.

Citation Information

Patent Citations

  • Animals fodder for composition Bacillus polyfermenticus

    KR100458487B1

  • A cosmetic composition comprising Bacillus polyfermenticus extract

    KR101843926B1

  • Pharmaceutical composition for removing and preventing tear staining in animal

    KR1020140127703A

  • Composition for improving dry eyes and preventing tear pigmentation for pets

    KR1020220002796A